Related Experiment Videos
[Multiple benefits of antenatal corticotherapy. Current status in th Belgian French community]
G Franckart1, X Kurz, J M Foidart
1Service de Néonatologie, CHR Citadelle, Université de Liège.
Insights
Antenatal corticosteroids significantly reduce respiratory distress and other serious complications in premature infants born before 34 weeks. This study supports routine antenatal corticosteroid use for improved neonatal outcomes.
Area of Science:
- Neonatal Medicine
- Pharmacology
Context:
- Antenatal administration of corticosteroids (betamethasone or dexamethasone) is a recognized intervention for premature infants.
- The study focuses on infants with birth weight below 1,500 g born between 1990-1994 in the Belgian French Community.
Purpose:
- To evaluate the impact of antenatal corticosteroid treatment on neonatal outcomes in a specific population.
- To advocate for the routine use of antenatal corticosteroids based on demonstrated clinical benefits.
Summary:
- Antenatal corticosteroids reduce respiratory distress syndrome, severe intraventricular hemorrhages, necrotizing enterocolitis, and neonatal mortality in premature infants.
- The study analyzed data from seven neonatal intensive care units in the Belgian French Community.
Impact:
- The findings support the routine antenatal use of corticosteroids, a cost-effective treatment with significant clinical benefits.
- This intervention improves survival and reduces morbidity in high-risk premature infants.
Abstract:
The benefit of antenatal administration of corticosteroids (betamethasone or dexamethasone) in the newborn prematured babies before the 34 week of gestation has been well demonstrated: reduction of respiratory distress syndrome but also a decrease in the incidence of severe intraventricular hemorrhages, episodes of necrotising enterocolitis and neonatal mortality. In this article, we report the impact of this treatment in the Belgian French Community in the population of infants with a birth weight below 1,500 g, born between 1990 and 1994 in the seven neonatal intensive care units. Based on this epidemiological study (compared with international publications) we propose the routine use of corticosteroids during the antenatal period, with the aim of seeing an increase in the use of this treatment, which, although costing little, produces clinical benefit.